Jasper Therapeutics, Inc.
JSPRNasdaqCIK 1788028HealthcareFiscal year ends Dec 31
Reports and events: 142 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1913:33 ET | DEF 14A | Proxy statementPeriod 2026-11-13 | 0001213900-26-110751 |
| 2026-10-1512:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-109587 |
| 2026-10-0712:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-107402 |
| 2026-10-0512:00 ET | 8-K | 5.07 Shareholder vote results | 0001213900-26-106651 |
| 2026-10-0522:54 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001213900-26-106574 |
| 2026-10-0121:29 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001213900-26-105924 |
| 2026-09-2820:44 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001213900-26-104101 |
| 2026-09-0419:08 ET | DEF 14A | Proxy statementPeriod 2026-09-30 | 0001213900-26-097572 |
| 2026-08-2620:15 ET | 8-K | 1.01 Entry into a material agreement | 0001213900-26-093979 |
| 2026-08-1420:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-090055 |
| 2026-08-1415:00 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001213900-26-089592 |
| 2026-08-0320:47 ET | 8-K | 5.07 Shareholder vote results | 0001213900-26-084687 |
| 2026-07-3110:06 ET | 8-K | 8.01 Other events | 0001213900-26-083563 |
| 2026-07-2021:01 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000921895-26-001834 |
| 2026-07-1701:50 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-078887 |
| 2026-07-1621:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-078781 |
| 2026-06-1520:03 ET | DEF 14A | Proxy statementPeriod 2026-07-31 | 0001213900-26-068765 |
| 2026-06-0920:05 ET | 8-K | 3.01 Delisting notice | 0001213900-26-066782 |
| 2026-06-0112:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-063157 |
| 2026-05-2120:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-060029 |
| 2026-05-1420:05 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001213900-26-056595 |
| 2026-05-1420:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-056596 |
| 2026-04-3020:01 ET | 10-K/A | Annual report, amendedPeriod 2025-12-31 | 0001213900-26-050178 |
| 2026-03-3021:33 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-036448 |
| 2026-03-3021:32 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001213900-26-036426 |
| 2026-01-0812:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-002329 |
| 2026-01-0721:35 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-002185 |
| 2025-12-0212:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-116943 |
| 2025-11-1013:17 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001213900-25-107884 |
| 2025-11-1013:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-107874 |
| 2025-09-2321:07 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000921895-25-002600 |
| 2025-09-1920:38 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-089584 |
| 2025-08-1320:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-075678 |
| 2025-08-1320:00 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001213900-25-075635 |
| 2025-07-0912:05 ET | 8-K | 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-062194 |
| 2025-07-0711:35 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-061632 |
| 2025-07-0320:01 ET | 8-K | 5.07 Shareholder vote results | 0001213900-25-061471 |
| 2025-06-1610:19 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-054465 |
| 2025-05-1912:00 ET | DEF 14A | Proxy statementPeriod 2025-07-03 | 0001213900-25-045086 |
| 2025-05-1220:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-042017 |
| 2025-05-1220:01 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001213900-25-042011 |
| 2025-03-1920:42 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001213900-25-025123 |
| 2025-02-2814:20 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001213900-25-018384 |
| 2025-02-2713:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-017656 |
| 2025-01-0812:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-001810 |
| 2024-11-0712:42 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-095175 |
| 2024-11-0712:30 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001213900-24-095173 |
| 2024-10-1510:03 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-087394 |
| 2024-08-1311:00 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001213900-24-067897 |
| 2024-06-2010:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-053982 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.